tiprankstipranks
Trending News
More News >
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is -2.13, suggesting Jagsonpal Pharmaceuticals Ltd. is a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 173.59, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 180.73, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points

Feb 28, 2026, 11:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
164.33
165.67
167.33
168.67
170.33
171.67
173.33
Fibonacci
165.67
166.81
167.52
168.67
169.81
170.52
171.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages

Feb 28, 2026, 11:33 PM
Period
Simple
Exponential
MA5
170.90Sell
170.60Sell
MA10
172.82Sell
172.17Sell
MA20
174.53Sell
173.59Sell
MA50
179.53Sell
180.73Sell
MA100
195.94Sell
192.79Sell
MA200
216.31Sell
207.43Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 172.17, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 192.79, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 179.53, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 195.94, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 216.31, creating a Sell signal.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators

Feb 28, 2026, 11:33 PM
Name
Value
Implied Action
RSI (14)
40.98
Neutral
STOCH (9,6)
22.47
Neutral
STOCHRSI (14)
14.65
Buy
MACD (12,26)
-2.13
Buy
ADX (14)
12.09
Buy
Williams %R
-86.08
Buy
CCI (14)
-109.16
Buy
ATR (14)
6.40
-
Ultimate Oscillator
58.05
Neutral
ROC
-6.24
Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 40.98, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 12.09, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is -109.16, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is -6.24, creating a Sell signal.

FAQ

Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Sell.
    What is JAGSNPHARM’s RSI (14)?
    JAGSNPHARM’s RSI (14) is 40.98, which suggests JAGSNPHARM is a Neutral.
      What is JAGSNPHARM’s MACD?
      JAGSNPHARM’s MACD is -2.13, which suggests JAGSNPHARM is a Buy.
        What is JAGSNPHARM’s 5-day moving average?
        JAGSNPHARM’s 5-day moving average is 170.90, which suggests JAGSNPHARM is a Sell.
          What is JAGSNPHARM’s 20-day moving average?
          JAGSNPHARM 20-day moving average is 174.53, which suggests JAGSNPHARM is a Sell.
            What is JAGSNPHARM’s 50-day moving average?
            JAGSNPHARM’s 50-day moving average is 179.53, which suggests JAGSNPHARM is a Sell.
              What is JAGSNPHARM’s 200-day moving average?
              JAGSNPHARM’s 200-day moving average is 216.31, which suggests JAGSNPHARM is a Sell.
                What is JAGSNPHARM’s Williams % R (14)?
                JAGSNPHARM’s Williams % R (14) is -86.08, which suggests JAGSNPHARM is a Buy.
                  What is JAGSNPHARM’s CCI (14)?
                  JAGSNPHARM’s CCI (14) is -109.16, which suggests JAGSNPHARM is a Buy.
                    What is the share price of Jagsonpal Pharmaceuticals Ltd.?